All drug substances and drug products require expiration dating. Data used to support and set expiry and shelf life must be collected and analyzed using guidelines set by regulatory agencies. Processes and considerations for small molecules are inadequate for large molecule therapeutics when planning for expiry dating. One issue to consider is that the complexity of large molecule therapeutics allows for a greater potential to lose potency through multiple pathways. This webinar addresses issues present when designing and implementing a stability program for large molecule therapeutics. Key topics will be addressed to provide insight into important issues that should be considered to assure maintenance of potency during
Course Objectives:
• Understanding the difference between stability for small molecules and large molecules or complex drug products
• Regulatory Expectations
• Special considerations for biologic stability
• Designing and validating stability indicating method
• Implementing a stability program
• Expiry dating
Background:
As with small molecule therapeutics, biologics require testing for stability. Documenting the stability of the biologic in different storage conditions is essential for setting specifications for expiry and shelf life. Understanding the possible pathways where degradation may occur is crucial to designing an appropriate stability program. Developing and validating stability indicating methods that assess possible pathways of degradation is important for the success of any stability program.
Why Should You Attend:
Biologics, as well as small molecule pharmaceutical products, require expiry dating. Data supporting expiry dating
Course Outline:
• Defining biologics
• Degradation pathways
• Areas of concern for
• Setting strategy to control stability
• Testing CQAs
• Stability indicating methods
• Test conditions, including stress conditions
• Data requirements
• Considerations for expiry dating
What You Get:
• Training Reference Materials
• Live Q&A with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Early Development and Product Design Personnel
• Process Design Personnel
• Quality Control Analyst
• Quality Assurance Personnel
• Lab Management
• Stability Personnel
• Manufacturing Personnel
• Shipping and Distribution Personnel
• Regulatory Affairs
• Drug Packaging Personnel
Drug Pharmacy Compounding
Get Instant Access 60 Minutes View Program |
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Get Instant Access 90 Minutes View Program |
Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
Get Instant Access 90 Minutes View Program |
Understanding The Regulation of Prescription Drugs
Get Instant Access 90 Minutes View Program |
Cosmetic Testing for US FDA Compliance
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry